BioLingus (Cayman) Limited (SUBL)
BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.
IPO Price
$20.00
Shares Offered
360,000
Deal Size
$7.20M

SUBL Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year 20222021
Net Income
-1.42-2.03
Depreciation & Amortization
0.160.22
Other Operating Activities
0.710.16
Operating Cash Flow
-0.55-1.65
Debt Issued / Paid
0.621.66
Financing Cash Flow
0.621.66
Net Cash Flow
0.070.01
Free Cash Flow
-0.55-1.65
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).